COVID vaccine safety data for children ‘extremely reassuring’ A new study tracking nearly 400,000 children aged 5–15 post-vaccination found adverse events were generally short-term and mild.
Almost one in every two Australians has had COVID-19 Survey taken from blood donors in June confirms that levels have increased exponentially since a similar study in March.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.
Testing concerns as COVID hospitalisations hit record levels More people are currently in hospital across Australia with COVID-19 than at any other time during the pandemic.
Call to expand access to self-test HIV kits Recent research shows the tests are accurate and easy to use, but availability is an ongoing issue.
Monkeypox declared global health emergency as WHO pushes containment GPs’ role ‘key’ as Australian health authorities reinforce efforts to keep a lid on the country’s case numbers.
Depression probably not caused by chemical imbalance: Study Over the past 30 years, the imbalance of serotonin has been identified as a potential cause of depression – but what does the evidence say?
CVD and diabetes rates spike post-COVID: Study The risk of contracting diabetes is especially high in the first four weeks after infection, but returns to baseline within months.
Australia’s first fixed pill-testing site opens in ACT The Chair of RACGP Specific Interests Addiction Medicine has welcomed the ‘highly significant’ launch, which is part of a six-month trial.
Slight rise in adverse reactions for joint COVID and flu jabs A peer-reviewed article looking at the co-administration of COVID booster and flu vaccines in the US reports that most reactions tend to be mild.